1. HBW Insight
  2. >>Wellness
  3. >>Business

Unilever Vows No GSK-Sized Ventures For Foreseeable Future, Commits To Existing Brands In 2022

 
• By Eileen Francis

Opening the company’s fiscal 2021 full-year earnings call, Unilever leadership assured investors it will not make any GSK-sized offers in the foreseeable future as it commits to organic growth and reshaping its portfolio more surgically through bolt-on deals and selective disposals.

Stock market (photofriday/Shutterstock.com)

Hearing the call of its investors, Unilever PLC has “drawn a line under the GSK Consumer Health proposal” and does not intend to pursue other major acquisitions in the foreseeable future, CEO & Executive Director Alan Jope told analysts during a 10 February year-end earnings presentation.

“We listened carefully to shareholders and we’ve heard the message that there’s currently no support for a move the size...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

Portfolios In Large US Food Industry Merger Cleared By FTC Include Nutritional Supplements

 
• By Malcolm Spicer

FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.

Stada CEO Has ‘Big Hopes’ For AI-Driven Personalized Healthcare

 
• By David Ridley

“Harnessing AI’s astounding abilities to improve people’s lives and relieve overburdened healthcare systems is one of the great opportunities of our time,” argues Stada CEO Peter Goldschmidt in the company's Health Report 2025.

Danone Acquires Belgian Firm Marketing Gut Health Supplement in US

 
• By Tom Gallen

Danone moves into dietary supplements space with deal for The Akkermansia Company marketing patented biotic strain in US, Europe and Asia.

Valbiotis Launches Plant-Based Heart Health Supplement

 
• By Tom Gallen

Available in French pharmacies and online, ValbiotisPRO Cardio-circulation comprises a blend of six plant extracts and is targeted at those with high blood pressure.

More from Wellness

US Adverse Event Report Forms Replace ‘Gender’ Options With Male Or Female ‘Sex’ Question

Modifications to forms FDA 3500, for voluntary reporting by healthcare professionals, and 3500A, for mandatory reporting by manufacturers, marketers or facilities, include limiting changing gender question to sex and asking for only male or female answer.

Kenvue’s Latest Tylenol Brand Launch Steers Consumers To Dietary Supplement Section

 
• By Malcolm Spicer

The firm doesn’t hold back on linking Muscle & Joint turmeric and tamarind formulation and Muscle & Joint + Stress also containing sceletium extract to the Tylenol brand while also pointing out that neither formulation contains acetaminophen

Valbiotis Launches Plant-Based Heart Health Supplement

 
• By Tom Gallen

Available in French pharmacies and online, ValbiotisPRO Cardio-circulation comprises a blend of six plant extracts and is targeted at those with high blood pressure.